132
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Vitamin D deficiency in patients operated on for gastric lymphoma

, , , , &
Pages 673-681 | Received 10 May 2005, Published online: 08 Jul 2009

References

  • Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1997; 29: 253–60
  • Glass AG, Karnell LH, Menck HR. The national cancer data base report on non-Hodgkin's lymphoma. Cancer 1997; 80: 2311–20
  • D'Amore F, Christensen BE, Brincker HK, Pedersen NT, Thorling K, Hastrup J, et al. Clinico-pathological features and prognostic factors in extranodal non-Hodgkin's lymphomas. Eur J Cancer 1991; 27: 1201–8
  • Herrmann, R, Panahon, AM, Barcos, MP, Walsh, D, Stutzman, L, , et al. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 1980;46:215–22.
  • D'Amore F, Brincker H, Gronbaek K, Thorling K, Pedersen M, Jensen MK, et al. Non-Hodgkin's lymphoma of the gastrointestinal tract. A population-based analysis of incidence, geographic distribution, clinico-pathologic presentation, features and prognosis. J Clin Oncol 1994; 12: 1673–84
  • Brands F, Monig SP, Raab M. Treatment and prognosis of gastric lymphoma. Eur J Surg 1997; 163: 803–13
  • Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelenyi G, et al. Updated Kiel classification for lymphomas [letter]. Lancet 1988; 8580: 292–3
  • Musshoff K. Klinische Stadieneinteilung der nicht-Hodgkin lymphome. Stralenterapie 1977; 153: 575–7
  • Fischbach W, Dragosics B, Kolve-Goebeler ME, Ohmann C, Greiner A, Yang Q, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German–Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology 2000; 119: 1191–202
  • Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma: results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001; 19: 3874–83
  • Binn M, Ruskone-Fourmestraux A, Lepage E, Haioun C, Delmer A, Aegerter P, et al. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol 2003; 14: 1751–7
  • Aviles A, Nambo MJ, Neri N, Huerta-Guzman J, Cuadra I, Alvarado I, et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann Surg 2004; 240: 44–50
  • Yoon SS, Coit DG, Portlock CS, Karpeh MS. The diminishing role of surgery in the treatment of gastric lymphoma. Ann Surg 2004; 240: 28–37
  • Al Akwaa AM, Siddiqui N, Al Mofleh IA. Primary gastric lymphoma. World J Gastroenterol 2004; 10: 5–11
  • Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575–7
  • Bertoni F, Conconi A, Capella C, Motta T, Giardini R, Ponzoni M, et al. International Extranodal Lymphoma Study Group; United Kingdom Lymphoma Group. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood 2002; 99: 2541–4
  • Weston AP, Banerjee SK, Horvat RT, Zoubine MN, Campbell DR, Cherian R. Prospective long-term endoscopic and histologic follow-up of gastric lymphoproliferative disease of early stage IE low-grade B-cell mucosa-associated lymphoid tissue type following Helicobacter pylori eradication treatment. Int J Oncol 1999; 15: 899–907
  • Adams JF. The clinical and metabolic consequences of total gastrectomy. I. Morbidity, weight and nutrition. Scand J Gastroenterol 1967; 2: 137–49
  • Tovey FI, Godfrey JE, Lewin MR. A gastrectomy population: 25–30 years on. Postgrad Med J 1990; 66: 450–6
  • Stael von Holstein C, Walther B, Ibrahimbegovic E, Akesson B. Nutritional status after total and partial gastrectomy with Roux-en-Y reconstruction. Br J Surg 1991; 78: 1084–7
  • Harju E. Metabolic problems after gastric surgery. Int Surg 1990; 75: 27–35
  • Rieu PN, Jansen JB, Joosten HJ, Lamers CB. Effect of gastrectomy with either Roux-en-Y or Billroth II anastomosis on small-intestinal function. Scand J Gastroenterol 1990; 25: 185–92
  • Iivonen MK, Mattila JJ, Nordback IH, Matikainen MJ. Long-term follow-up of patients with jejunal pouch reconstruction after total gastrectomy. A randomized prospective study. Scand J Gastroenterol 2000; 35: 679–85
  • Liedman B, Bosaeus I, Hugosson I, Lundell L. Long-term beneficial effects of a gastric reservoir on weight control after total gastrectomy: a study of potential mechanisms. Br J Surg 1998 Apr; 85(4)542–7
  • Roviello F, Fotia G, Marrelli D, De Stefano A, Macchiarelli R, Pinto E. Iron deficiency anemia after subtotal gastrectomy for gastric cancer. Hepatogastroenterology 2004; 51: 1510–4
  • Esko H. Lack of body iron after total gastrectomy for adenocarcinoma of the stomach: a serum ferritin follow-up. Int Surg 1985; 70: 319–22
  • Stael von Holstein C, Ibrahimbegovic E, Walther B, Akesson B. Nutrient intake and biochemical markers of nutritional status during long-term follow-up after total and partial gastrectomy. Eur J Clin Nutr 1992; 46: 265–72
  • Zittel TT, Zeeb B, Maier GW, Kaiser GW, Zwirner M, Liebich H, et al. High prevalence of bone disorders after gastrectomy. Am J Surg 1997; 174: 431–8
  • Schmiedl A, Schwille PO, Stuhler C, Gohl J, Rumenapf G. Low bone mineral density after total gastrectomy in males: a preliminary report emphasizing the possible significance of urinary net acid excretion, serum gastrin and phosphorus. Clin Chem Lab Med 1999; 37: 739–44
  • Resch H, Pietschmann P, Pernecker B, Krexner E, Willvonseder R. The influence of partial gastrectomy on biochemical parameters of bone metabolism and bone density. Clin Invest 1992; 70: 426–9
  • Krogsgaard MR, Frolich A, Lund B, Lund B. Long-term changes in bone mass after partial gastrectomy in a well-defined population and its relation to tobacco and alcohol consumption. World J Surg 1995; 19: 867–71
  • Kobayashi S, Takahashi C, Kuroda T, Sugenoya A, Iida F, Katoh K. Calcium regulating hormones and bone mineral content in patients after subtotal gastrectomy. Surg Today 1994; 24: 295–8
  • Jaffe ES, Harris NL, Stein H, Vardiman JW. Tumours of haematopoietic and lypmhoid tissus. Pathology and genetics. WHO classification of tumours. IARC Press, Lyon 2001
  • Mowe M, Bøhmer T, Haug E. Serum calcidiol and calcitriol concentrations in elderly people: variation with age, sex, season and disease. Clin Nutr 1996; 15: 2001–6
  • Davies M, Heys SE, Selby PL, Berry JL, Mawer EB. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease. J Clin Endocrinol Metab 1997; 82: 209–12
  • Maier GW, Kreis ME, Zittel TT, Becker HD. Calcium regulation and bone mass loss after total gastrectomy in pigs. Ann Surg 1997; 225: 181–92
  • Tovey FI, Hall ML, Ell PJ, Hobsley M. Cyclical etidronate therapy and postgastrectomy osteoporosis. Br J Surg. 1994; 81: 1168–9
  • Rino Y, Imada T, Yamamoto Y, Takahashi M, Amano T, Takanashi Y. The efficacy of 1 alpha hydroxyvitamin D3 treatment of the metabolic bone disorder in patients who underwent gastrectomy for gastric cancer. Hepatogastroenterology 2000; 47: 1498–500
  • Bisballe S, Eriksen EF, Melsen F, Mosekilde L, Sorensen OH, Hessov I. Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone. Gut 1991; 32: 1303–7
  • Bernstein CN. Osteomalacia after gastrectomy. Gut 1992; 33: 1151–2
  • de Bree A, Verschuren WM, Blom HJ, Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20–65 y. Am J Clin Nutr 2001; 73: 1027–33
  • Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998; 67: 263–70
  • Quinlivan EP, McPartlin J, McNulty H, Ward M, Strain JJ, Weir DG, et al. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 2002; 359: 227–8
  • McCaddon A, Hudson P, Ellis D, Hill D, Lloyd A. Effect of supplementation with folic-acid on relation between plasma homocysteine, folate, and vitamin B12. Lancet 2002; 360: 173
  • Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocyteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049–57
  • Elkelboom JW, Lonn E, Genest J, Jr, Hankey G, Yusuf S. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131: 363–75
  • Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Ann Rev Med 1998; 49: 31–62

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.